Behçet's disease (Q57213634)

Seminars in Ophthalmology

Europe PubMed Central

title

Behçet's disease (English)

0 references

0 references

Adriana A Bonfioli

1

0 references

Fernando Orefice

series ordinal

2

0 references

language of work or name

English

0 references

published in

0 references

volume

20

0 references

issue

3

0 references

page(s)

199-206

0 references

1 reference

https://api.crossref.org/works/10.1080/08820530500231953

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820530500231953

Low dose cyclosporin A versus pulsed cyclophosphamide in Behçet's syndrome: a single masked trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820530500231953

Novel approaches to Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820530500231953

A controlled trial of azathioprine in Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820530500231953

Azathioprine in Behcet's syndrome: effects on long-term prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820530500231953

Long-lasting remission of Behcet's disease after chlorambucil therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820530500231953

Chlorambucil in the treatment of uveitis and meningoencephalitis of Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820530500231953

Immunotherapy for Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820530500231953

Interferon-alpha 2a treatment of neuro-Behcet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820530500231953

Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820530500231953

Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820530500231953

The use of interferon alpha in Behçet disease: review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820530500231953

Differential efficacy of human recombinant interferon-alpha2a on ocular and extraocular manifestations of Behçet disease: results of an open 4-center trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820530500231953

Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet's disease: use of neurophysiological studies to detect thalidomide neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820530500231953

Effect of infliximab on sight-threatening panuveitis in Behçet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820530500231953